hepatitis-b

Im Datensatz "Inanspruchnahme von Routineimpfungen in Deutschland – Ergebnisse aus der KV-Impfsurveillance" des Robert Koch-Instituts werden die Impfquoten in der gesetzlich krankenversicherten Bevölkerung Deutschlands bereitgestellt. Nach dem Infektionsschutzgesetz (IfSG) übermitteln alle 17 kassenärztlichen Vereinigungen seit 2020 quartalsweis...

Here's an implementation of the Hepatits B deterministic and controlled model derived in the paper mensioned in the README using pythons numpy and matplotlib. In addition to the notebook there is a desktop application that takes the model parameters and creates solution plots for the model.

A full-stack ML-powered web application for early risk prediction of Ovarian Cancer, PCOS, and Hepatitis B, enabling data-driven clinical decision support.

Novira Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Novira Therapeutics was a biopharmaceutical company developing direct-acting antivirals for chronic hepatitis B (HBV), notably HBV capsid assembly modulators. It was acquired by Johnson & Johnson (Janssen) in 2015 and no longer operates as an independe

cn — independent third-party profile of a public API surface, by API Evangelist. cn is the China-region web presence (cn.ausperbio.com) of AusperBio Therapeutics (Hangzhou Ausper Bio / 杭州浩博医药有限公司), a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment toward a functional cure and advancing oligonucleotide thera

Vongi Health (芝兰健康) — independent third-party profile of a public API surface, by API Evangelist. Vongi Health (芝兰健康, Hangzhou Zhilan Health Co., Ltd., also branded Slan Health) is a Qiming Venture Partners-backed Chinese digital therapeutics company founded in Hangzhou in 2015. Its hepatitis B mother-to-child transmission prevention digital therap

Free, open-source registry for portable clinical obligations. Nothing found should be lost.